Taxus Cardium Pharmaceuticals Price on January 19, 2023

CRXMDelisted Stock  USD 0.0001  0.00  0.00%   
If you're considering investing in Taxus Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Taxus Cardium stands at 0.0001, as last reported on the 18th of December 2024, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day. We have found three technical indicators for Taxus Cardium Pharmaceuticals, which you can use to evaluate the volatility of the company.
  
Taxus Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
CRXM
Based on monthly moving average Taxus Cardium is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Taxus Cardium by adding Taxus Cardium to a well-diversified portfolio.

Taxus Cardium Valuation on January 19, 2023

It is possible to determine the worth of Taxus Cardium on a given historical date. On January 19, 2023 Taxus was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Taxus Cardium pink sheet. Still, in general, we apply an absolute valuation method to find Taxus Cardium's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Taxus Cardium where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Taxus Cardium's related companies.
 Open High Low Close Volume
  0.0001    0.0001    0.0001    0.0001    1.00  
01/19/2023
  0.0001    0.0001    0.0001    0.0001    1.00  
  0.0001    0.0001    0.0001    0.0001    150.00  
Backtest Taxus Cardium  |  Taxus Cardium History  |  Taxus Cardium Valuation   PreviousNext  
Open Value
1.0E-4
1.0E-4
Closing Value
0.00
Upside

Taxus Cardium Trading Date Momentum on January 19, 2023

On January 20 2023 Taxus Cardium Pharmaceuticals was traded for  0.0001  at the closing time. The top price for the day was 0.0001  and the lowest listed price was  0.0001 . The trading volume for the day was 150. The trading history from January 20, 2023 did not result in any price rise and fall. The trading price change against the current closing price is 0.00% .

Taxus Cardium Pharma Fundamentals Correlations and Trends

By evaluating Taxus Cardium's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Taxus Cardium's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Taxus financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Taxus Cardium Pink Sheet history

Taxus Cardium investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Taxus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Taxus Cardium Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Taxus Cardium stock prices may prove useful in developing a viable investing in Taxus Cardium
Gene Biotherapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of angiogenic gene therapy biotherapeutics for the treatment of cardiovascular diseases in the United States. Gene Biotherapeutics, Inc. was incorporated in 2003 and is headquartered in San Diego, California. Taxus Cardium operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.

Taxus Cardium Pink Sheet Technical Analysis

Taxus Cardium technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Taxus Cardium technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Taxus Cardium trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Taxus Cardium Period Price Range

Low
December 18, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Taxus Cardium Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Taxus Cardium December 18, 2024 Market Strength

Market strength indicators help investors to evaluate how Taxus Cardium pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Taxus Cardium shares will generate the highest return on investment. By undertsting and applying Taxus Cardium pink sheet market strength indicators, traders can identify Taxus Cardium Pharmaceuticals entry and exit signals to maximize returns
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Consideration for investing in Taxus Pink Sheet

If you are still planning to invest in Taxus Cardium Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taxus Cardium's history and understand the potential risks before investing.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Global Correlations
Find global opportunities by holding instruments from different markets
CEOs Directory
Screen CEOs from public companies around the world